Correlation Between Kelly Strategic and Invesco Nasdaq

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kelly Strategic and Invesco Nasdaq at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kelly Strategic and Invesco Nasdaq into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kelly Strategic Management and Invesco Nasdaq Biotechnology, you can compare the effects of market volatilities on Kelly Strategic and Invesco Nasdaq and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kelly Strategic with a short position of Invesco Nasdaq. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kelly Strategic and Invesco Nasdaq.

Diversification Opportunities for Kelly Strategic and Invesco Nasdaq

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Kelly and Invesco is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Kelly Strategic Management and Invesco Nasdaq Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invesco Nasdaq Biote and Kelly Strategic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kelly Strategic Management are associated (or correlated) with Invesco Nasdaq. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invesco Nasdaq Biote has no effect on the direction of Kelly Strategic i.e., Kelly Strategic and Invesco Nasdaq go up and down completely randomly.

Pair Corralation between Kelly Strategic and Invesco Nasdaq

If you would invest  1,518  in Kelly Strategic Management on September 29, 2024 and sell it today you would earn a total of  0.00  from holding Kelly Strategic Management or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy1.56%
ValuesDaily Returns

Kelly Strategic Management  vs.  Invesco Nasdaq Biotechnology

 Performance 
       Timeline  
Kelly Strategic Mana 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kelly Strategic Management has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Kelly Strategic is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.
Invesco Nasdaq Biote 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Invesco Nasdaq Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Etf's fundamental drivers remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the ETF retail investors.

Kelly Strategic and Invesco Nasdaq Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kelly Strategic and Invesco Nasdaq

The main advantage of trading using opposite Kelly Strategic and Invesco Nasdaq positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kelly Strategic position performs unexpectedly, Invesco Nasdaq can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invesco Nasdaq will offset losses from the drop in Invesco Nasdaq's long position.
The idea behind Kelly Strategic Management and Invesco Nasdaq Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals